Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer

Clin Chem. 2004 Aug;50(8):1445-7. doi: 10.1373/clinchem.2004.035493. Epub 2004 May 27.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Crk-Associated Substrate Protein
  • Enzyme-Linked Immunosorbent Assay
  • Estrogen Antagonists / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Predictive Value of Tests
  • Proteins / analysis*
  • Retinoblastoma-Like Protein p130
  • Tamoxifen / therapeutic use*

Substances

  • BCAR1 protein, human
  • Biomarkers, Tumor
  • Crk-Associated Substrate Protein
  • Estrogen Antagonists
  • Proteins
  • Retinoblastoma-Like Protein p130
  • Tamoxifen